Articles
11 June 2009
Vol. 2 No. 15: Secondary Leukemias and leukemogenesis Rome, 3-4 November 2006
https://doi.org/10.4081/hmr.v2i15.514

Epigenetic pathways in hematological malignancies

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
234
Views
318
Downloads

Authors

Santiago Ropero
support@pagepress.org
It has been recognized for many years that tumors develop as a result of accumulated molecular-genetic or genomic alterations. However, cancer development is not restricted to the genetic changes, but also to epigenetic changes. The inheritance of information based on gene expression levels in known as epigenetics, as opposed to genetics, which refers to information transmitted on the basis of gene sequence. To date, DNA methylation and the post-tranductional modifications of histone proteins are the best studied epigenetic modifications.

Altmetrics

Downloads

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Supporting Agencies

How to Cite



Epigenetic pathways in hematological malignancies. (2009). Hematology Meeting Reports (formerly Haematologica Reports), 2(15). https://doi.org/10.4081/hmr.v2i15.514